NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT

Bone Marrow Transplantation

Volumn 49, Issue 4, 2014, Pages 561-566

  Williams, K M ^a,b   Hnatiuk, O ^c   Mitchell, S A ^a   Baird, K ^a   Gadalla, S M ^a   Steinberg, S M ^d   Shelhamer, J ^d   Carpenter, A ^a   Avila, D ^a   Taylor, T ^a   Grkovic, L ^e   Pulanic, D ^e   Comis, L E ^d   Blacklock Schuver, B ^a   Gress, R E ^a   Pavletic, S Z ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c VA Medical Center   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e KBC Zagreb   (Croatia)

Author keywords

Bronchiolitis obliterans syndrome; Chronic GVHD; Pulmonary function equation; hematopoietic SCT

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHIOLITIS OBLITERANS; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EARLY DIAGNOSIS; ETHNICITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOABLATIVE CONDITIONING; OXYGEN THERAPY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; VERY ELDERLY; ADOLESCENT; ALLOTRANSPLANTATION; CHRONIC DISEASE; COHORT ANALYSIS; GRAFT VS HOST DISEASE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BRONCHIOLITIS OBLITERANS; CHILD; CHRONIC DISEASE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EARLY DIAGNOSIS; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84897561289     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.222     Document Type: Article

References (37)

1. Williams KM, Chien JW, Gladwin MT, Pavletic SZ. Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. Jama 2009; 302: 306-314.
2. Clark JG, Crawford SW, Madtes DK, Sullivan KM. Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 1989; 111: 368-376.
3. Dudek AZ, Mahaseth H, DeFor TE, Weisdorf DJ. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 2003; 9: 657-666.
4. Nishio N, Yagasaki H, Takahashi Y, Muramatsu H, Hama A, Tanaka M et al. Late-onset non-infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation in children. Bone Marrow Transplant 2009; 44: 303-308.
5. Santo Tomas LH, Loberiza Jr FR, Klein JP, Layde PM, Lipchik RJ, Rizzo JD et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest 2005; 128: 153-161.
6. Au BK, Au MA, Chien JW. Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2010; 17: 1072-1078.
7. White DA, Wong PW, Downey R. The utility of open lung biopsy in patients with hematologic malignancies. Am J Respir Crit Care Med 2000; 161(3 Pt 1): 723-729.
8. Suzuki T, Saijo Y, Ebina M, Yaekashiwa M, Minegishi M, Tsuchiya S et al. Bilateral pneumothoraces with multiple bullae in a patient with asymptomatic bronchiolitis obliterans 10 years after bone marrow transplantation. Bone Marrow Transplant 1999; 23: 829-831.
9. Chadwick C, Marven SM, Vora AJ. Autologous blood pleurodesis for pneumothorax complicating graft-versus-host disease-related bronchiolitis obliterans. Bone Marrow Transplant 2004; 33: 451-453.
10. Kumar S, Tefferi A. Spontaneous pneumomediastinum and subcutaneous emphysema complicating bronchiolitis obliterans after allogeneic bone marrow transplantation - case report and review of literature. Ann Hematol 2001; 80: 430-435.
11. Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2006; 12: 138-151.
12. Chien JW, Martin PJ, Gooley TA, Flowers ME, Heckbert SR, Nichols WG et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003; 168: 208-214.
13. Pavletic SZ, Martin P, Lee SJ, Mitchell S, Jacobsohn D, Cowen EW et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant 2006; 12: 252-266.
14. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956.
15. Chien JW, Duncan S, Williams KM, Pavletic SZ. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2010; 16(1 Suppl): S106-S114.
16. Gunn ML, Godwin JD, Kanne JP, Flowers ME, Chien JW, High-resolution CT. findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. J Thorac Imaging 2008; 23: 244-250.
17. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179-187.
18. Roberts CM, MacRae KD, Winning AJ, Adams L, Seed WA. Reference values and prediction equations for normal lung function in a non-smoking white urban population. Thorax 1991; 46: 643-650.
19. Collen J, Greenburg D, Holley A, King C, Roop S, Hnatiuk O. Racial discordance in spirometry comparing four commonly used reference equations to the National Health and Nutrition Examination Study III. Respir Med 2010; 104: 705-711.
20. Collen J, Greenburg D, Holley A, King CS, Hnatiuk O. Discordance in spirometric interpretations using three commonly used reference equations vs national health and nutrition examination study III. Chest 2008; 134: 1009-1016.
21. Society AT. Lung Function Testing: Selection of Reference values and interpretative strategies. American Thoracic Society 1991, Contract No. 1202, 144: 1202-1218.
22. Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction: Use percentage of FEV1/FVC ratio below the fifth percentile, noto70%. Chest 2007; 131: 349-355.
23. Baird K, Steinberg SM, Grkovic L, Pulanic D, Cowen EW, Mitchell SA et al. National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis. Biol Blood Marrow Transplant 2013; 19: 632-639.
24. Grkovic L, Baird K, Steinberg SM, Williams KM, Pulanic D, Cowen EW et al. Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity. Leukemia 2012; 26: 633-643.
25. Martires KJ, Baird K, Steinberg SM, Grkovic L, Joe GO, Williams KM et al. Sclerotictype chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease. Blood 2011; 118: 4250-4257.
26. Lim S, MacRae KD, Seed WA, Roberts CM. The value of forced expiratory volume in 1 s in screening subjects with stable COPD for PaO2o7.3 kPa qualifying for long-term oxygen therapy. Respir Med 1998; 92: 1122-1126.
27. Gassas A, Craig-Barnes H, Dell S, Doyle J, Schechter T, Sung L et al. Chest health surveillance utility in the early detection of bronchiolitis obliterans syndrome in children after allo-SCT. Bone Marrow Transplant 2013; 48: 814-818.
28. Reynaud-Gaubert M, Thomas P, Badier M, Cau P, Giudicelli R, Fuentes P. Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings. Am J Respir Crit Care Med 2000; 161: 1924-1929.
29. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
30. Hildebrandt GC, Fazekas T, Lawitschka A, Bertz H, Greinix H, Halter J et al. Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD. Bone Marrow Transplant 2011; 46: 1283-1295.
31. Bacigalupo A, Chien J, Barisione G, Pavletic S. Late pulmonary complications after allogeneic hematopoietic stem cell transplantation: diagnosis, monitoring, prevention, and treatment. Semin Hematol 2012; 49: 15-24.
32. Uhlving HH, Buchvald F, Heilmann CJ, Nielsen KG, Gormsen M, Muller KG. Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options. Bone Marrow Transplant 2012; 47: 1020-1029.
33. Lam DC, Lam B, Wong MK, Lu C, Au WY, Tse EW et al. Effects of azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT - a randomized double-blinded placebo-controlled study. Bone Marrow Transplant 2011; 46: 1551-1556.
34. Nakasone H, Kanda J, Yano S, Atsuta Y, Ago H, Fukuda T et al. A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation. Transplant Int 2013; 26: 631-639.
35. Bergeron A, Godet C, Chevret S, Lorillon G, Peffault de Latour R, de Revel T et al. Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis. Bone Marrow Transplant 2013; 48: 819-824.
36. Hostettler KE, Halter JP, Gerull S, Lardinois D, Savic S, Roth M et al. Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation. Eur Respir J (e-pub ahead of print 3 May 2013).
37. Duarte RF, Greinix H, Rabin B, Mitchell SA, Basak G, Wolff D et al. Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT-NCI Chronic GVHD Task Force. Bone Marrow Transplant 2014; 49: 49-54.